Related Experiment Videos
[Interrelations between macroorganisms and bacteria in wounds and tissues of humans and animals]
Abstract:
It is shown that bacteria from the gastrointestinal tract penetrate systematically into the tissues of the focus of damage in man and animals in the blood and lymph. It was found that certain bacterial species maintain vitality in tissues, in which they do not induce pathological reactions but may produce a therapeutic effect due to the production of antibiotics, proteolytic enzymes, immunomodulators, etc. The author describes the results of experimental and clinical study of Sporobacterin, a new agent, intended for the prevention and treatment of surgical infection.
Insights
Bacteria from the gut can enter damaged tissues and some species offer therapeutic benefits. A new agent, Sporobacterin, shows promise for preventing and treating surgical infections.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Context:
- Bacteria from the gastrointestinal tract can translocate to damaged tissues in humans and animals via the bloodstream and lymphatic system.
- Certain resident bacteria in tissues do not cause harm but can exert beneficial therapeutic effects.
- These beneficial effects stem from the production of bioactive molecules like antibiotics, proteolytic enzymes, and immunomodulators.
Purpose:
- To investigate the systemic translocation of gastrointestinal bacteria into damaged tissues.
- To identify bacterial species that maintain viability in tissues and exert therapeutic effects.
- To evaluate the efficacy of a novel agent, Sporobacterin, for surgical infection management.
Summary:
- Gastrointestinal bacteria can systematically enter damaged tissues, with some species demonstrating a therapeutic potential.
- These bacteria can produce beneficial substances such as antibiotics and immunomodulators.
- Experimental and clinical studies on Sporobacterin, a new agent for surgical infection, are presented.
Impact:
- Highlights the potential of commensal bacteria in therapeutic applications.
- Introduces Sporobacterin as a potential new treatment for surgical infections.
- Suggests a paradigm shift in understanding host-microbe interactions in wound healing and infection control.